Veraxa Biotech Holding AG
Status: Publicly traded
Direct answer
Veraxa Biotech Holding AG is publicly traded on NASDAQ under the ticker VRXA.
Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]
Can you invest in Veraxa Biotech Holding AG?
Yes. Veraxa Biotech Holding AG trades publicly on NASDAQ as VRXA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Veraxa Biotech Holding AG
Detailed equity research is provided by MarketSnap.